Potential for Drug Repositioning of Midazolam as an Inhibitor of Inflammatory Bone Resorption
Open Access
- 12 July 2024
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (14) , 7651
Abstract
Drug repositioning is a method for exploring new effects of existing drugs, the safety and pharmacokinetics of which have been confirmed in humans. Here, we demonstrate the potential drug repositioning of midazolam (MDZ), which is used for intravenous sedation, as an inhibitor of inflammatory bone resorption. We cultured a mouse macrophage-like cell line with or without MDZ and evaluated its effects on the induction of differentiation of these cells into osteoclasts. For in vivo investigations, we administered lipopolysaccharide (LPS) together with MDZ (LPS+MDZ) to the parietal region of mice and evaluated the results based on the percentage of bone resorption and calvaria volume. Furthermore, we examined the effects of MDZ on the production of reactive oxygen species (ROS) in cells and on its signaling pathway. MDZ inhibited osteoclast differentiation and bone resorption activity. In animal studies, the LPS+MDZ group showed a decreasing trend associated with the rate of bone resorption. In addition, the bone matrix volume in the LPS+MDZ group was slightly higher than in the LPS only group. MDZ inhibited osteoclast differentiation by decreasing ROS production and thereby negatively regulating the p38 mitogen-activated protein kinase pathway. Thus, we propose that MDZ could potentially be used for treating inflammatory bone resorption, for example, in periodontal disease.Keywords
Funding Information
- Japan Society for the Promotion of Science (JP21K09945, JP22K10027)
This publication has 40 references indexed in Scilit:
- Histological evaluation of nonsurgical periodontal treatment with and without the use of sodium hypochlorite / amino acids and cross-linked hyaluronic acid gels in dogsClinical Oral Investigations, 2024
- BushenHuoxue decoction suppresses M1 macrophage polarization and prevents LPS induced inflammatory bone loss by activating AMPK pathwayHeliyon, 2023
- Roles of osteoclasts in alveolar bone remodelingGenesis, 2022
- An exploratory clinical trial to evaluate the safety and efficacy of combination therapy of REGROTH® and Cytrans® granules for severe periodontitis with intrabony defectsRegenerative Therapy, 2022
- Histological evaluation of extraction sites grafted with Bio-Oss Collagen: Randomized controlled trialAnnals of Anatomy - Anatomischer Anzeiger, 2021
- Molecular regulatory mechanisms of osteoclastogenesis through cytoprotective enzymesRedox Biology, 2016
- The Role of Enamel Matrix Proteins in the Development of Cementum and Periodontal Tissues2007
- An ROS generator, antimycin A, inhibits the growth of HeLa cells via apoptosisJournal of Cellular Biochemistry, 2007
- EFFECT OF MIDAZOLAM ON INTERLEUKIN-6 mRNA EXPRESSION IN HUMAN PERIPHERAL BLOOD MONONUCLEAR CELLS IN THE ABSENCE OF LIPOPOLYSACCHARIDECytokine, 2001
- Emdogain - periodontal regeneration based on biomimicryClinical Oral Investigations, 2000